Literature DB >> 21551249

Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.

Debra A Mayes1, Tilat A Rizvi, Jose A Cancelas, Nathan T Kolasinski, Georgianne M Ciraolo, Anat O Stemmer-Rachamimov, Nancy Ratner.   

Abstract

Plexiform neurofibromas are peripheral nerve sheath tumors initiated by biallelic mutation of the NF1 tumor suppressor gene in the Schwann cell lineage. To understand whether neurofibroma formation is possible after birth, we induced Nf1 loss of function with an inducible proteolipid protein Cre allele. Perinatal loss of Nf1 resulted in the development of small plexiform neurofibromas late in life, whereas loss in adulthood caused large plexiform neurofibromas and morbidity beginning 4 months after onset of Nf1 loss. A conditional EGFP reporter allele identified cells showing recombination, including peripheral ganglia satellite cells, peripheral nerve S100β+ myelinating Schwann cells, and peripheral nerve p75+ cells. Neurofibromas contained cells with Remak bundle disruption but no recombination within GFAP+ nonmyelinating Schwann cells. Extramedullary lympho-hematopoietic expansion was also observed in PlpCre;Nf1fl/fl mice. These tumors contained EGFP+/Sca-1+ stromal cells among EGFP-negative lympho-hematopoietic cells indicating a noncell autonomous effect and unveiling a role of Nf1-deleted microenvironment on lympho-hematopoietic proliferation in vivo. Together these findings define a tumor suppressor role for Nf1 in the adult and narrow the range of potential neurofibroma-initiating cell populations. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551249      PMCID: PMC3464476          DOI: 10.1158/0008-5472.CAN-10-4558

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.

Authors:  Ophélia Maertens; Hilde Brems; Jo Vandesompele; Thomas De Raedt; Ine Heyns; Thorsten Rosenbaum; Sofie De Schepper; Anne De Paepe; Geert Mortier; Sandra Janssens; Frank Speleman; Eric Legius; Ludwine Messiaen
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

Review 2.  The origin and development of glial cells in peripheral nerves.

Authors:  Kristjan R Jessen; Rhona Mirsky
Journal:  Nat Rev Neurosci       Date:  2005-09       Impact factor: 34.870

3.  Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system.

Authors:  Tomoki Nakamura; Melissa C Colbert; Jeffrey Robbins
Journal:  Circ Res       Date:  2006-05-18       Impact factor: 17.367

Review 4.  Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation.

Authors:  Rhona Mirsky; Ashwin Woodhoo; David B Parkinson; Peter Arthur-Farraj; Ambily Bhaskaran; Kristján R Jessen
Journal:  J Peripher Nerv Syst       Date:  2008-06       Impact factor: 3.494

5.  Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Authors:  Benjamin C Ling; Jianqiang Wu; Shyra J Miller; Kelly R Monk; Rania Shamekh; Tilat A Rizvi; Gabrielle Decourten-Myers; Kristine S Vogel; Jeffrey E DeClue; Nancy Ratner
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

Review 6.  Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.

Authors:  J M Woodruff
Journal:  Am J Med Genet       Date:  1999-03-26

7.  Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad.

Authors:  Narihito Nagoshi; Shinsuke Shibata; Yoshiaki Kubota; Masaya Nakamura; Yasuo Nagai; Etsuko Satoh; Satoru Morikawa; Yohei Okada; Yo Mabuchi; Hiroyuki Katoh; Seiji Okada; Keiichi Fukuda; Toshio Suda; Yumi Matsuzaki; Yoshiaki Toyama; Hideyuki Okano
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

8.  Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.

Authors:  Jianqiang Wu; Jon P Williams; Tilat A Rizvi; Jennifer J Kordich; David Witte; Dies Meijer; Anat O Stemmer-Rachamimov; Jose A Cancelas; Nancy Ratner
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

9.  The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

Authors:  Nancy M Joseph; Jack T Mosher; Johanna Buchstaller; Paige Snider; Paul E McKeever; Megan Lim; Simon J Conway; Luis F Parada; Yuan Zhu; Sean J Morrison
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

10.  Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.

Authors:  Huarui Zheng; Lou Chang; Neha Patel; Jiong Yang; Lori Lowe; Dennis K Burns; Yuan Zhu
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

View more
  34 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 2.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

3.  Microprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for schwann cell myelination and myelin maintenance.

Authors:  Hsin-Pin Lin; Idil Oksuz; Edward Hurley; Lawrence Wrabetz; Rajeshwar Awatramani
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1

Authors:  Julie A Mund; SuJung Park; Abbi E Smith; Yongzheng He; Li Jiang; Eric Hawley; Michelle J Roberson; Dana K Mitchell; Mohannad Abu-Sultanah; Jin Yuan; Waylan K Bessler; George Sandusky; Shi Chen; Chi Zhang; Steven D Rhodes; D Wade Clapp
Journal:  J Biol Chem       Date:  2020-05-29       Impact factor: 5.157

5.  Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.

Authors:  Ki H Ma; Holly A Hung; Rajini Srinivasan; Huafeng Xie; Stuart H Orkin; John Svaren
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

6.  Sustained MAPK/ERK Activation in Adult Schwann Cells Impairs Nerve Repair.

Authors:  Ilaria Cervellini; Jorge Galino; Ning Zhu; Shannen Allen; Carmen Birchmeier; David L Bennett
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

7.  Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.

Authors:  Vincent Chau; S Kyun Lim; Wei Mo; Chiachi Liu; Amish J Patel; Renée M McKay; Shuguang Wei; Bruce A Posner; Jef K De Brabander; Noelle S Williams; Luis F Parada; Lu Q Le
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

Review 8.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

9.  Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

Authors:  Adrienne L Watson; Eric P Rahrmann; Branden S Moriarity; Kwangmin Choi; Caitlin B Conboy; Andrew D Greeley; Amanda L Halfond; Leah K Anderson; Brian R Wahl; Vincent W Keng; Anthony E Rizzardi; Colleen L Forster; Margaret H Collins; Aaron L Sarver; Margaret R Wallace; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Cancer Discov       Date:  2013-03-27       Impact factor: 39.397

10.  Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.

Authors:  Stephanie N Brosius; Amy N Turk; Stephanie J Byer; Nicole M Brossier; Latika Kohli; Amber Whitmire; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Acta Neuropathol       Date:  2014-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.